Transoral Robotic Surgery for Early-T Stage Glottic Cancer Involving the Anterior Commissure—News and Update

BackgroundAbout 20% of all glottic carcinomas involve the anterior commissure (AC), and AC involvement was deemed to be a risk factor of local recurrence and poor prognosis. Transoral robotic surgery (TORS) has been developed for a panoramic view of the AC and en-bloc resection of the tumor by multi...

Full description

Bibliographic Details
Main Authors: Chen-Chi Wang, Wen-Jiun Lin, Jing-Jie Wang, Chien-Chih Chen, Kai-Li Liang, Yen-Jung Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.755400/full
_version_ 1818985772821250048
author Chen-Chi Wang
Chen-Chi Wang
Chen-Chi Wang
Wen-Jiun Lin
Jing-Jie Wang
Jing-Jie Wang
Chien-Chih Chen
Chien-Chih Chen
Kai-Li Liang
Kai-Li Liang
Yen-Jung Huang
author_facet Chen-Chi Wang
Chen-Chi Wang
Chen-Chi Wang
Wen-Jiun Lin
Jing-Jie Wang
Jing-Jie Wang
Chien-Chih Chen
Chien-Chih Chen
Kai-Li Liang
Kai-Li Liang
Yen-Jung Huang
author_sort Chen-Chi Wang
collection DOAJ
description BackgroundAbout 20% of all glottic carcinomas involve the anterior commissure (AC), and AC involvement was deemed to be a risk factor of local recurrence and poor prognosis. Transoral robotic surgery (TORS) has been developed for a panoramic view of the AC and en-bloc resection of the tumor by multidirectional dissection with endo-wristed instruments. With satisfactory preliminary results, we would like to update the data with a bigger cohort and present the news on using TORS for salvage treatment of recurrence from irradiation failure.MethodsFrom July 2010 to December 2019, 22 patients with early T1 and 2 stage primary (n = 11) or recurrent (n = 11) glottic cancer with AC involvement received TORS without adjuvant therapy. TORS exposure was found to be better than TLM by conventional laryngoscopy in diagnostic biopsy. Seven of the 22 patients had recurrent cancer from irradiation failure. The perioperative factors that may be associated with survival were retrospectively analyzed, and the 5-year overall survival (OS)/disease-specific survival (DSS)/recurrence-free survival (RFS)/and organ preservation survival (OPS) rate were estimated by the Kaplan–Meier Method. Their voice and swallowing functions were evaluated by questionnaires of Voice Handicap Index-10 (VHI-10) and Functional Outcome Swallowing Scale (FOSS).ResultsAll 22 TORSs were completed smoothly. After a mean follow-up of 49 ± 35.9 months, the Kaplan–Meier method estimated 5-year OS/DSS/RFS/OPS was 93.8%, 93.8%, 74.6%, and 86.3%, respectively. Our 11 patients with fresh cancer had 100% recurrence-free survival. Although the recurrent rate was higher in patients with history of RT, they could be rescued by further open laryngectomy without compromising the OS and DSS. Only one patient expired. The other 21 patients had satisfactory swallowing function with FOSS of 0.33 ± 0.66. Five patients depended on tracheostomy, but the rest 17 patients had serviceable voice with VHI-10 of 18.41 ± 11.29.ConclusionsTORS could be used in the primary or salvage management of glottic cancer with AC involvement while TORS was confirmed to have better exposure to TLM. The RFS was good for patients with primary cancer. In patients having irradiation failure, TORS could also be a minimally invasive transoral approach before trying open surgery to preserve the organ.
first_indexed 2024-12-20T18:40:13Z
format Article
id doaj.art-c641c1701cc24b7eb4bb68105e3b4aba
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-20T18:40:13Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-c641c1701cc24b7eb4bb68105e3b4aba2022-12-21T19:29:49ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-01-011210.3389/fonc.2022.755400755400Transoral Robotic Surgery for Early-T Stage Glottic Cancer Involving the Anterior Commissure—News and UpdateChen-Chi Wang0Chen-Chi Wang1Chen-Chi Wang2Wen-Jiun Lin3Jing-Jie Wang4Jing-Jie Wang5Chien-Chih Chen6Chien-Chih Chen7Kai-Li Liang8Kai-Li Liang9Yen-Jung Huang10School of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanDepartment of Otolaryngology-Head & Neck Surgery, Taichung Veterans General Hospital, Taichung, TaiwanDepartment of Audiology and Speech-Language Pathology, Asia University, Taichung, TaiwanDepartment of Otolaryngology-Head & Neck Surgery, Taichung Veterans General Hospital, Taichung, TaiwanDepartment of Otolaryngology-Head & Neck Surgery, Taichung Veterans General Hospital, Taichung, TaiwanInstitute of Medicine, Chung Shan Medical University, Taichung, TaiwanDepartment of Radiation Oncology, Taichung Veterans General Hospital, Taichung, TaiwanPh.D. Program in Translational Medicine, National Chung-Hsing University, Taichung, TaiwanSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanDepartment of Otolaryngology-Head & Neck Surgery, Taichung Veterans General Hospital, Taichung, TaiwanDepartment of Otolaryngology-Head & Neck Surgery, Taichung Veterans General Hospital, Taichung, TaiwanBackgroundAbout 20% of all glottic carcinomas involve the anterior commissure (AC), and AC involvement was deemed to be a risk factor of local recurrence and poor prognosis. Transoral robotic surgery (TORS) has been developed for a panoramic view of the AC and en-bloc resection of the tumor by multidirectional dissection with endo-wristed instruments. With satisfactory preliminary results, we would like to update the data with a bigger cohort and present the news on using TORS for salvage treatment of recurrence from irradiation failure.MethodsFrom July 2010 to December 2019, 22 patients with early T1 and 2 stage primary (n = 11) or recurrent (n = 11) glottic cancer with AC involvement received TORS without adjuvant therapy. TORS exposure was found to be better than TLM by conventional laryngoscopy in diagnostic biopsy. Seven of the 22 patients had recurrent cancer from irradiation failure. The perioperative factors that may be associated with survival were retrospectively analyzed, and the 5-year overall survival (OS)/disease-specific survival (DSS)/recurrence-free survival (RFS)/and organ preservation survival (OPS) rate were estimated by the Kaplan–Meier Method. Their voice and swallowing functions were evaluated by questionnaires of Voice Handicap Index-10 (VHI-10) and Functional Outcome Swallowing Scale (FOSS).ResultsAll 22 TORSs were completed smoothly. After a mean follow-up of 49 ± 35.9 months, the Kaplan–Meier method estimated 5-year OS/DSS/RFS/OPS was 93.8%, 93.8%, 74.6%, and 86.3%, respectively. Our 11 patients with fresh cancer had 100% recurrence-free survival. Although the recurrent rate was higher in patients with history of RT, they could be rescued by further open laryngectomy without compromising the OS and DSS. Only one patient expired. The other 21 patients had satisfactory swallowing function with FOSS of 0.33 ± 0.66. Five patients depended on tracheostomy, but the rest 17 patients had serviceable voice with VHI-10 of 18.41 ± 11.29.ConclusionsTORS could be used in the primary or salvage management of glottic cancer with AC involvement while TORS was confirmed to have better exposure to TLM. The RFS was good for patients with primary cancer. In patients having irradiation failure, TORS could also be a minimally invasive transoral approach before trying open surgery to preserve the organ.https://www.frontiersin.org/articles/10.3389/fonc.2022.755400/fullcancerglottislarynxradiotherapysurvival, anterior commissureswallowing
spellingShingle Chen-Chi Wang
Chen-Chi Wang
Chen-Chi Wang
Wen-Jiun Lin
Jing-Jie Wang
Jing-Jie Wang
Chien-Chih Chen
Chien-Chih Chen
Kai-Li Liang
Kai-Li Liang
Yen-Jung Huang
Transoral Robotic Surgery for Early-T Stage Glottic Cancer Involving the Anterior Commissure—News and Update
Frontiers in Oncology
cancer
glottis
larynx
radiotherapy
survival, anterior commissure
swallowing
title Transoral Robotic Surgery for Early-T Stage Glottic Cancer Involving the Anterior Commissure—News and Update
title_full Transoral Robotic Surgery for Early-T Stage Glottic Cancer Involving the Anterior Commissure—News and Update
title_fullStr Transoral Robotic Surgery for Early-T Stage Glottic Cancer Involving the Anterior Commissure—News and Update
title_full_unstemmed Transoral Robotic Surgery for Early-T Stage Glottic Cancer Involving the Anterior Commissure—News and Update
title_short Transoral Robotic Surgery for Early-T Stage Glottic Cancer Involving the Anterior Commissure—News and Update
title_sort transoral robotic surgery for early t stage glottic cancer involving the anterior commissure news and update
topic cancer
glottis
larynx
radiotherapy
survival, anterior commissure
swallowing
url https://www.frontiersin.org/articles/10.3389/fonc.2022.755400/full
work_keys_str_mv AT chenchiwang transoralroboticsurgeryforearlytstageglotticcancerinvolvingtheanteriorcommissurenewsandupdate
AT chenchiwang transoralroboticsurgeryforearlytstageglotticcancerinvolvingtheanteriorcommissurenewsandupdate
AT chenchiwang transoralroboticsurgeryforearlytstageglotticcancerinvolvingtheanteriorcommissurenewsandupdate
AT wenjiunlin transoralroboticsurgeryforearlytstageglotticcancerinvolvingtheanteriorcommissurenewsandupdate
AT jingjiewang transoralroboticsurgeryforearlytstageglotticcancerinvolvingtheanteriorcommissurenewsandupdate
AT jingjiewang transoralroboticsurgeryforearlytstageglotticcancerinvolvingtheanteriorcommissurenewsandupdate
AT chienchihchen transoralroboticsurgeryforearlytstageglotticcancerinvolvingtheanteriorcommissurenewsandupdate
AT chienchihchen transoralroboticsurgeryforearlytstageglotticcancerinvolvingtheanteriorcommissurenewsandupdate
AT kaililiang transoralroboticsurgeryforearlytstageglotticcancerinvolvingtheanteriorcommissurenewsandupdate
AT kaililiang transoralroboticsurgeryforearlytstageglotticcancerinvolvingtheanteriorcommissurenewsandupdate
AT yenjunghuang transoralroboticsurgeryforearlytstageglotticcancerinvolvingtheanteriorcommissurenewsandupdate